Salim Yazji

Insider Reports History

Entity
Individual
Location
12230 El Camino Real, Suite 300, San Diego, CA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salim Yazji:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Medical Officer Common Stock 129K $63.8K $0.50 Jan 3, 2024 Direct
Oncternal Therapeutics, Inc. Chief Medical Officer Stock Option 14.2K Feb 14, 2024 Direct

Insider Reports Filed by Salim Yazji

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2024 1 -$9.79K 4 Jan 5, 2024 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Oct 2, 2023 9 $0 4 Oct 4, 2023 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jul 3, 2023 1 -$5.87K 4 Jul 5, 2023 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Apr 12, 2023 3 $7.2K 4 Apr 14, 2023 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2023 1 -$10.2K 4 Jan 5, 2023 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jan 27, 2022 1 $16.9K 4 Jan 31, 2022 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Medical Officer
ONCT Oncternal Therapeutics, Inc. May 25, 2021 0 $0 3 May 27, 2021 Chief Medical Officer